Your browser doesn't support javascript.
loading
Effect of allopurinol drug use on GFR and proteinuria in patients with renal transplant recipients (ADOPTR study).
Usalan, Özlem; Sahin, Ahmet Ziya; Özdemir, Orhan; Cingöz, Mukaddes; Usalan, Celalettin.
Afiliación
  • Usalan Ö; Gaziantep University School of Medicine, Department of Nephrology, Gaziantep, Turkey.
  • Sahin AZ; Gaziantep University School of Medicine, Department of Nephrology, Gaziantep, Turkey. Electronic address: drahmetziya@hotmail.com.
  • Özdemir O; Gaziantep University School of Medicine, Department of Nephrology, Gaziantep, Turkey.
  • Cingöz M; Sehitkamil State Hospital, Department of Internal Medicine, Gaziantep, Turkey.
  • Usalan C; Gaziantep University School of Medicine, Department of Nephrology, Gaziantep, Turkey.
Transpl Immunol ; 72: 101560, 2022 06.
Article en En | MEDLINE | ID: mdl-35245661
BACKGROUND: Hyperuricemia has been associated with the development of hypertension, cardiovascular, and renal disease. However, there is no data about the effect of lowering uric acid level on renal functions and proteinuria in renal transplant recipients. This study aimed to investigate the effect of allopurinol treatment on renal functions in renal transplant recipients (RTR). METHODS: A total of 245 patients with renal transplantation were included in this randomized, placebo-controlled study. Patients were randomized to receive either placebo (121 patients) or 300 mg/day allopurinol (124 patients). We have examined uric acid, urinary protein creatinin ratio, MDRD (the modification of diet in renal diseases) and CRP (C-reactive protein) before and 24 weeks after treatment in both group. RESULTS: In the allopurinol group, the mean serum uric acid levels, eGFR (estimated glomerular filtration rate), and creatinine urinary albumin creatinin ratio (UACR) significantly improved (p < 0.001). Also uric acid level was positively correlated with the UACR (r = 0,645 p < 0.001) and negatively correlated with MDRD (r = -0,387 p < 0.05) in allopurinol treatment group. A statistically significant increase in CRP level was observed (p < 0,05) in plasebo group. Multivariate regression analysis showed that uric acid was positively correlated with UACR (r = 0,473, ß = 0.021, p = 0.002) and negatively correlated with MDRD (r = -0554 ß = 0.016, P = 0.001) in allopurinol treatment RTR. CONCLUSION: Urate, a salt of uric acid, is lowered by allopurinol treatment resulting in improved eGFR and decreased proteinuria, when compared to the placebo group. Therefore, we suggest that allopurinol therapy should be part of the management of kidney transplant patients with normal kidney function. Long-term follow-up studies will be useful in revealing the effect of uric acid management on kidney functions and proteinuria.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Riñón / Enfermedades Renales Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Transpl Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA / TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Riñón / Enfermedades Renales Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Transpl Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA / TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Países Bajos